On 11 December, Moscow hosted the XV Indian-Russian Business Dialogue, a key event aimed at strengthening bilateral relations and promoting economic cooperation between the two countries. The event brought together leading politicians, business leaders, and experts to discuss key economic issues and explore new opportunities for collaboration.
Vsevolod Tyupa, Head of Life Sciences and Healthcare, participated in specialised session with focus on innovations in healthcare, biotechnology, technology, and education. The participants discussed breakthroughs and opportunities for technology-driven solutions in healthcare and pharmaceuticals as well as shared successful cases of production localisation in Russia and Russian medical business entry to the international markets.
In his presentation, Vsevolod spoke about the Code of Ethics for the use of artificial intelligence in healthcare as well as provided comparative information on the AI regulation in the EU and India. He also brought invaluable insights and profound understanding of the life sciences and healthcare businesses, serving as the head of the practice at SEAMLESS Legal.
The speakers of the round table included the reputable representatives of Sun Pharma, Mastech Pharm, Osteo-Sibear, IRE-Polus, Pharmexcil, Promomed, Skolkovo, Moscow Export Centre and Eurasian Federation of Oncology.
The India-Russia Business Dialogue is the main platform for discussing issues related to the prospects of expanding Russian-Indian interaction, strengthening strategic cooperation, developing bilateral trade and establishing new business ties.
Life Sciences & Healthcare is an important practice area at SEAMLESS Legal. The firm provides support to companies in the pharmaceutical, medical devices, healthcare, food and other life science industries. Additionally, SEAMLESS Legal implements complex international healthcare projects from entering into the market and launching of innovative products to becoming the recognized market leaders.
The material is also available in Russian.